Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9495)
All Articles published online
|
Publishing Process of This Article
|
Feb 6, 2016 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 41-50 [PMID: 26855811 DOI: 10.4292/wjgpt.v7.i1.41] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v7/i1/41.htm |
| Number | Citing Articles |
| 1 |
Fabio Corsi, Luca Sorrentino, Sara Albasini, Francesco Colombo, Maria Cigognini, Alessandro Massari, Carlo Morasso, Serena Mazzucchelli, Francesca Piccotti, Sandro Ardizzone, Gianluca M. Sampietro, Marta Truffi. Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725726
|
| 2 |
Fadi H. Mourad, Yunki Yau, Valerie C. Wasinger, Rupert W. Leong. Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models. Digestive Diseases and Sciences 2017; 62(9): 2266 doi: 10.1007/s10620-017-4673-0
|
| 3 |
V A Akhmedov, O V Gaus. Pancreatic diseases and inflammatory bowel diseases: a random or regular combination?. Terapevticheskii arkhiv 2020; 92(1): 76 doi: 10.26442/00403660.2020.01.000463
|
| 4 |
Katharina Schönauen, Nha Le, Ulrike von Arnim, Christian Schulz, Peter Malfertheiner, Alexander Link. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2018; 24(7): 1547 doi: 10.1093/ibd/izy046
|
| 5 |
Khaled Alkhuder. Fourier-transform infrared spectroscopy: A universal optical sensing technique with auspicious application prospects in the diagnosis and management of autoimmune diseases. Photodiagnosis and Photodynamic Therapy 2023; 42: 103606 doi: 10.1016/j.pdpdt.2023.103606
|
| 6 |
Gursimran Kochhar, Bret Lashner. Utility of Biomarkers in the Management of Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 2017; 15(1): 105 doi: 10.1007/s11938-017-0129-z
|
| 7 |
Z. Linneman, C. Reis, K. Balaji, J. Moore, S. Braude. The vitamin D positive feedback hypothesis of inflammatory bowel diseases. Medical Hypotheses 2019; 127: 154 doi: 10.1016/j.mehy.2019.04.005
|
| 8 |
NorahMohammed Almarri, AlaaJamal Alobaidli, AhmedAbdullah Almarhabi, MohammedAhmed Alshammari. Acute pancreatitis as an initial presentation of Crohn's disease: A case report. Journal of Family Medicine and Primary Care 2019; 8(11): 3752 doi: 10.4103/jfmpc.jfmpc_753_19
|
| 9 |
Mingshan Jiang, Zhen Zeng, Kexin Chen, Yuan Dang, Lili Li, Chunxiang Ma, Rui Cheng, Kehan Hu, Xi Li, Hu Zhang. Enterogenous Microbiotic Markers in the Differential Diagnosis of Crohn’s Disease and Intestinal Tuberculosis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.820891
|
| 10 |
Reza Yarani, Ali Shojaeian, Oana Palasca, Nadezhda T. Doncheva, Lars Juhl Jensen, Jan Gorodkin, Flemming Pociot. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865777
|
| 11 |
Wojciech Marlicz, Karolina Skonieczna-Żydecka, Konstantinos John Dabos, Igor Łoniewski, Anastasios Koulaouzidis. Emerging concepts in non-invasive monitoring of Crohn’s disease. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818769076
|
| 12 |
Beata Wilenska, Dagmara Tymecka, Marcin Włodarczyk, Aleksandra Sobolewska-Włodarczyk, Maria Wiśniewska-Jarosińska, Jolanta Dyniewicz, Árpád Somogyi, Jakub Fichna, Aleksandra Misicka. Enkephalin degradation in serum of patients with inflammatory bowel diseases. Pharmacological Reports 2019; 71(1): 42 doi: 10.1016/j.pharep.2018.08.001
|
| 13 |
Hanan Balto, Solaiman Al-Hadlaq, Abdulmalik Alhadlaq, Afaf El-Ansary. Gum-gut axis: The potential role of salivary biomarkers in the diagnosis and monitoring progress of inflammatory bowel diseases. The Saudi Dental Journal 2023; 35(1): 24 doi: 10.1016/j.sdentj.2022.12.006
|
| 14 |
Marisa Iborra, Javier Pérez-Gisbert, Marta Maia Bosca-Watts, Alicia López-García, Valle García-Sánchez, Antonio López-Sanromán, Esther Hinojosa, Lucía Márquez, Santiago García-López, María Chaparro, Montserrat Aceituno, Margalida Calafat, Jordi Guardiola, Blanca Belloc, Yolanda Ber, Luis Bujanda, Belén Beltrán, Cristina Rodríguez-Gutiérrez, Jesús Barrio, José Luis Cabriada, Montserrat Rivero, Raquel Camargo, Manuel van Domselaar, Albert Villoria, Hugo Salata Schuterman, David Hervás, Pilar Nos. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients. Journal of Gastroenterology 2017; 52(7): 788 doi: 10.1007/s00535-016-1274-1
|
| 15 |
Yu. A. Khalitova, Yu. V. Myakisheva, S. E. Katorkin, P. S. Andreev, D. S. Gromova. Clinical and biochemical status of patients with ulcerative collitis. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 2022; (5): 66 doi: 10.20340/vmi-rvz.2022.5.CLIN.7
|
| 16 |
Yilin Huang, Yang Wang, Xiaotian Huang, Xiaomin Yu. Unveiling the overlooked fungi: the vital of gut fungi in inflammatory bowel disease and colorectal cancer. Gut Pathogens 2024; 16(1) doi: 10.1186/s13099-024-00651-7
|
| 17 |
Majken Lindholm, Tina Manon-Jensen, Gunvor Iben Madsen, Aleksander Krag, Morten Asser Karsdal, Jens Kjeldsen, Joachim Høg Mortensen. Extracellular Matrix Fragments of the Basement Membrane and the Interstitial Matrix Are Serological Markers of Intestinal Tissue Remodeling and Disease Activity in Dextran Sulfate Sodium Colitis. Digestive Diseases and Sciences 2019; 64(11): 3134 doi: 10.1007/s10620-019-05676-6
|
| 18 |
Aleksandra Kałużna, Agnieszka Jura-Półtorak, Alicja Derkacz, Julia Jaruszowiec, Krystyna Olczyk, Katarzyna Komosinska-Vassev. Circulating Profiles of Serum Proguanylin, S100A12 Protein and Pentraxin 3 as Diagnostic Markers of Ulcerative Colitis. Journal of Clinical Medicine 2023; 12(13): 4339 doi: 10.3390/jcm12134339
|
| 19 |
Koji Yoshino, Takayuki Nakayama, Ayumu Ito, Eiichi Sato, Shigehisa Kitano. Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6138-7
|
| 20 |
Eddie X. Shen, Anton Lord, James D. Doecke, Katherine Hanigan, James Irwin, Richard K.Y. Cheng, Graham Radford‐Smith. A validated risk stratification tool for detecting high‐risk small bowel Crohn's disease. Alimentary Pharmacology & Therapeutics 2020; 51(2): 281 doi: 10.1111/apt.15550
|
| 21 |
Uri Netz, Jane Carter, M Robert Eichenberger, Kayla Feagins, Norman J Galbraith, Gerald W Dryden, Jianmin Pan, Shesh N Rai, Susan Galandiuk. Plasma microRNA Profile Differentiates Crohn’s Colitis From Ulcerative Colitis. Inflammatory Bowel Diseases 2018; 24(1): 159 doi: 10.1093/ibd/izx009
|
| 22 |
Reza Yarani, Aashiq H. Mirza, Simranjeet Kaur, Flemming Pociot. The emerging role of lncRNAs in inflammatory bowel disease. Experimental & Molecular Medicine 2018; 50(12): 1 doi: 10.1038/s12276-018-0188-9
|
| 23 |
Kei Motooka, Koichi Morishita, Nami Ito, Shinichiro Shinzaki, Taku Tashiro, Satoshi Nojima, Kayoko Shimizu, Mutsuhiro Date, Natsumi Sakata, Momoko Yamada, Shinji Takamatsu, Yoshihiro Kamada, Hideki Iijima, Tsunekazu Mizushima, Eiichi Morii, Tetsuo Takehara, Eiji Miyoshi. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis. World Journal of Gastroenterology 2021; 27(2): 162-175 doi: 10.3748/wjg.v27.i2.162
|
| 24 |
Chi Wang, Han-Shi Zeng, Kai-Xuan Liu, Yi-Na Lin, Hao Yang, Xin-Ying Xie, Dai-Xu Wei, Jian-Wen Ye. Biosensor-based therapy powered by synthetic biology. Smart Materials in Medicine 2023; 4: 212 doi: 10.1016/j.smaim.2022.10.003
|
| 25 |
Francesca Palone, Roberta Vitali, Salvatore Cucchiara, Maurizio Mennini, Alessandro Armuzzi, Daniela Pugliese, Renata DʼIncà, Brigida Barberio, Laura Stronati. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission. Inflammatory Bowel Diseases 2016; 22(12): 2886 doi: 10.1097/MIB.0000000000000938
|
| 26 |
Bjoern Titz, Raffaella M. Gadaleta, Giuseppe Lo Sasso, Ashraf Elamin, Kim Ekroos, Nikolai V. Ivanov, Manuel C. Peitsch, Julia Hoeng. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification. International Journal of Molecular Sciences 2018; 19(9): 2775 doi: 10.3390/ijms19092775
|
| 27 |
Rui Zhou, Peishan Qiu, Haizhou Wang, Huijie Yang, Xueying Yang, Mingliang Ye, Fan Wang, Qiu Zhao. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease. Aging 2021; 13(3): 4634 doi: 10.18632/aging.202428
|
| 28 |
Eguzkiñe Diez-Martin, Leidi Hernandez-Suarez, Carmen Muñoz-Villafranca, Leire Martin-Souto, Egoitz Astigarraga, Andoni Ramirez-Garcia, Gabriel Barreda-Gómez. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. International Journal of Molecular Sciences 2024; 25(13): 7062 doi: 10.3390/ijms25137062
|
| 29 |
Lucille Quénéhervé, Grégoire David, Arnaud Bourreille, Jean Benoît Hardouin, Gabriel Rahmi, Michel Neunlist, Jérémy Brégeon, Emmanuel Coron. Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases. Gastrointestinal Endoscopy 2019; 89(3): 626 doi: 10.1016/j.gie.2018.08.006
|
| 30 |
Daniel Sprockett, Natalie Fischer, Rotem Sigall Boneh, Dan Turner, Jarek Kierkus, Malgorzata Sladek, Johanna C Escher, Eytan Wine, Baruch Yerushalmi, Jorge Amil Dias, Ron Shaoul, Michal Kori, Scott B Snapper, Susan Holmes, Athos Bousvaros, Arie Levine, David A Relman. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn’s Disease Cohort. Inflammatory Bowel Diseases 2019; 25(12): 1927 doi: 10.1093/ibd/izz130
|
| 31 |
James M. Gray, Kristin Knight, Vu Q. Nguyen, Marrieth G. Rubio, Lauren Irby, James H. Boone, Dario Sorrentino. Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature. Inflammatory Intestinal Diseases 2020; 5(3): 151 doi: 10.1159/000508970
|
| 32 |
Efe Sezgin, Gamze Terlemez, Berkay Bozkurt, Göksel Bengi, Hale Akpinar, İlker Büyüktorun. Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease. PeerJ 2022; 10: e14217 doi: 10.7717/peerj.14217
|
| 33 |
Charalampia Amerikanou, Eirini Dimitropoulou, Aristea Gioxari, Efstathia Papada, Anthi Tanaini, Charalambos Fotakis, Panagiotis Zoumpoulakis, Andriana C. Kaliora. Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with Mastiha. Biomedicine & Pharmacotherapy 2021; 138: 111535 doi: 10.1016/j.biopha.2021.111535
|
| 34 |
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023; 13(3): 378 doi: 10.3390/metabo13030378
|
| 35 |
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2016; 26(4): 641 doi: 10.1016/j.giec.2016.06.005
|
| 36 |
Raheleh Heydari, Padideh Karimi, Anna Meyfour. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease. Biomedicine & Pharmacotherapy 2024; 176: 116868 doi: 10.1016/j.biopha.2024.116868
|
| 37 |
Iolanda Agliata, Nora Fernandez-Jimenez, Chloe Goldsmith, Julien C. Marie, Jose R. Bilbao, Robert Dante, Hector Hernandez-Vargas. The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cells. Epigenetics 2020; 15(10): 1068 doi: 10.1080/15592294.2020.1748916
|
| 38 |
Anita Bálint, Barbara Dorottya Lovász. Editorial: Game Changers in Inflammatory Bowel Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.795597
|
| 39 |
Aleksandra Górecka, Agnieszka Jura-Półtorak, Ewa M. Koźma, Anna Szeremeta, Krystyna Olczyk, Katarzyna Komosińska-Vassev. Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression. Molecules 2024; 29(19): 4577 doi: 10.3390/molecules29194577
|